Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 46 Neoplasms 32 Lung Neoplasms 25 Colorectal Neoplasms 22 Uterine Cervical Neoplasms 14 Prostatic Neoplasms 13 Motor Activity 11 Colonic Neoplasms 10 Anxiety Disorders 9 Rectal Neoplasms 8 Pancreatic Neoplasms 8 Obesity 8 Carcinoma, Non-Small-Cell Lung 8 Hematologic Neoplasms 7 Endometrial Neoplasms 7 Depression 7 Ovarian Neoplasms 6 Lymphoma 6 Breast Carcinoma In Situ 6 Vulvar Neoplasms 5 Urinary Bladder Neoplasms 5 Neoplasm Metastasis 5 Hematopoietic and Lymphatic System Neoplasm 5 Triple Negative Breast Neoplasms 4 Smoking Cessation 4 Pain 4 Melanoma 4 Leukemia, Myeloid, Acute 4 Hematopoietic and Lymphoid System Neoplasm 4 Head and Neck Neoplasms 4

Interventions

Telemedicine 1 Tablets 1 Methods 1 Mass Screening 1 Magnetic Resonance Imaging 1 Lysine Acetyltransferase 5 1 Hypnosis 1 Ethanol 1 Electroencephalography 1 Control Groups 1 Amyloid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Alzheimer Disease × Methods × Clear all

NCT07332377 2026-03-18

PsyMINT

Virginia Commonwealth University

Phase NA Recruiting

Agnosia, Alzheimer Disease, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡